Human Bone Graft in Epiphysiodesis

Last updated: August 23, 2022
Sponsor: Medical University of Vienna
Overall Status: Active - Recruiting

Phase

N/A

Condition

Acromegaly

Treatment

N/A

Clinical Study ID

NCT04067895
EP1
  • Ages 10-18
  • All Genders

Study Summary

This observational study is to document the application of human bone graft in the surgical treatment (epiphysiodesis) of leg length discrepancy or primordial gigantism and its subsequent healing process.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Planned epiphysiodesis to stop the growing of a bone indicated by leg lengthdiscrepancies or primordial gigantism
  • Age 10-18 years
  • Written consent to participate in the study after previous written and oral education (additional consent for the participation of minors in the study after prior writtenand oral education by at least one parent)

Exclusion

Exclusion Criteria:

  • Insufficient knowledge of the german language
  • Foreseeable compliance issues
  • Neoplastic diseases, malignant bone tumors, rheumatoid arthritis
  • Patients with non-treated pre-existing conditions, which could be the cause of leglength differences
  • Active osteomyelitis
  • Ulcerations in the area of the skin of the surgical area
  • Immunosuppressive drugs that can not be discontinued

Study Design

Total Participants: 20
Study Start date:
August 06, 2019
Estimated Completion Date:
September 30, 2024

Connect with a study center

  • General Hospital Vienna

    Vienna, 1090
    Austria

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.